SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Pushing Frontiers of Adaptive Immunity
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
An Infant bNAb With Low Somatic Hypermutation Contributes to Polyclonal Breadth
Cassandra Simonich
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
Virus, Host, and Disease Factors Govern HIV-1 Broadly Neutralizing Antibody Induction
Alexandra Trkola
University of Zurich, Zurich, Switzerland
Clinical Safety and Pharmacokinetics of IV and SC VRC01, a Broadly Neutralizing mAb
Kenneth H. Mayer
The Fenway Institute, Fenway Health, Boston, MA, United States
Neutrophil Functions Induced by Gp-120 Specific IgA and IgG; Clues for Immunotherapy
Magdalena Sips
Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
Potency and Kinetics of Autologous HIV-1 Neutralizing Antibody Responses During ATI
Brenda Salantes
University of Pennsylvania, Philadelphia, PA, United States
PD-1 Blockade as an Adjunct Therapy to ART and Potential to Destabilize SIV Reservoir
Geetha Mylvaganam
Emory University, Atlanta, GA, United States
Follicular CTL Accumulate in SIV-Infected Lymph Nodes Due to Immune Activation
Costantinos Petrovas
National Institutes of Health, Bethesda, MD, United States
Repeated TLR7 Agonist Treatment of SIV+ Monkeys on ART Can Lead to Viral Remission
James B. Whitney
Beth Israel Deaconess Medical Center, Boston, MA, United States
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
